Trump Announces HHS, CMS Picks

President-elect Donald Trump chooses Representative Tom Price to lead the Department of Health and Human Services, Seema Verma to lead the Centers for Medicare and Medicaid Services.

Written byJoshua A. Krisch
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Tom Price

FLICKR, GAGE SKIDMOREThe incoming US President has tapped Representative Tom Price (R-GA), an orthopedic surgeon, to serve as the country’s next Department of Health and Human Services (HHS) secretary. In this role, Price would hold the purse strings for medical research funding (namely through the National Institutes of Health), oversee agencies that regulate food and drugs (US Food and Drug Administration), and likely work to implement proposed changes to the Affordable Care Act.

“The practicing physician and the patient could not have a better friend in that office than Tom Price,” Representative Michael Burgess (R-TX) told The New York Times. Senator Chuck Schumer (D-NY) disagreed. “Nominating Congressman Price to be the HHS secretary is akin to asking the fox to guard the henhouse,” he told the New York Times.

One of Price’s most significant duties as HHS secretary would be managing budgetary decisions at the NIH, putting him in control of more than $1 trillion in annual biomedical research funding. Price has long opposed embryonic stem cell research, and once told STAT News ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies